发明名称 COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY
摘要 Compounds of formula (I) defined herein act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for the prevention and/or treatment of broncho-obstructive or inflammatory diseases.
申请公布号 US2015139916(A1) 申请公布日期 2015.05.21
申请号 US201514609524 申请日期 2015.01.30
申请人 CHIESI FARMACEUTICI S.p.A. 发明人 RANCATI Fabio;Linney Ian;Knight Chris;Schmidt Wolfgang
分类号 C07D453/02;A61K9/00;A61K45/06;A61K31/4709;A61K31/496 主分类号 C07D453/02
代理机构 代理人
主权项 1. A compound represented by formula (I):wherein Q is Q1, Q2, or Q3 Z is H or OH; Y is Y′ or Y1 which are divalent groups of formula wherein A1 and A2 are independently absent or are (C1-C6)alkylene, (C3-C8)cycloalkylene, or (C3-C8)heterocycloalkylene optionally substituted by one or more substituents selected from the group consisting of (C1-C6)alkyl, aryl(C1-C6)alkyl, and heteroaryl(C1-C6)alkyl;B is absent or is (C3-C8)cycloalkylene, (C3-C8)heterocycloalkylene, arylene, or heteroarylene, optionally substituted by one or more groups selected from the group consisting of halogen, nitrile, linear or branched (C1-C6)alkyl, linear or branched (C1-C6)haloalkyl, (C1-C6)alkoxy, aryl, aryl(C1-C6)alkyl, —NR7(R8) and heteroaryl;C and C′ are absent, or are independently —O—, —CO—, —OC(O)—, —C(OO)—, or one of the following groups C1-C14 wherein R7, R7′ and R8 are independently H or linear or branched (C1-C6)alkyl, (C3-C8)cycloalkyl, (C3-C8)cycloalkyl(C1-C6)alkyl, (C3-C8)heterocycloalkyl(C1-C6)alkyl, aryl, or aryl(C1-C6)alkyl, optionally substituted by one or more substituents selected from the group consisting of (C1-C6)alkyl, halo(C1-C6)alkyl, halogen atom, (C1-C6)alkoxy, and halo(C1-C6)alkoxy;D is absent or is (C1-C6)alkylene, arylene, heteroarylene, and (C3-C8)heterocycloalkylene, optionally substituted by one or more (C1-C6)alkyl groups;n, n′, m and p are independently 0 or an integer from 1 to 3;E is absent or is —O— or —OC(O)—; G is arylene optionally substituted by one or more substituents selected from the group consisting of halogen atom, —OH, oxo (═O), —SH, —NO2, —CN, and —NH2; R1 and R2 are independently H or (C1-C6)alkyl or aryl, optionally substituted by one or more halogen atoms; M is —N(R3)—; R3 is H or (C1-C6)alkyl; R4 is a group of formula J1or a pharmaceutically acceptable salt thereof.
地址 Parma IT